Cargando...
The development of proteinase-activated receptor-2 modulators and the challenges involved
Protease-activated receptor-2 (PAR2) has been extensively studied since its discovery in the mid-1990. Despite the advances in understanding PAR2 pharmacology, it has taken almost 25 years for the first inhibitor to reach clinical trials, and so far, no PAR2 antagonist has been approved for human us...
Gardado en:
| Publicado en: | Biochem Soc Trans |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Portland Press Ltd.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752072/ https://ncbi.nlm.nih.gov/pubmed/33242065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BST20200191 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|